INCRESYNC 25/30mg 28tab

INCRESYNC 25/30 mg Tablets – 28 Tablets
Active Ingredients: Sitagliptin 25 mg / Metformin 30 mg
Therapeutic Class: Oral Antidiabetic – DPP-4 Inhibitor + Biguanide

Description:
INCRESYNC combines sitagliptin, a DPP-4 inhibitor that enhances insulin secretion and lowers glucagon, with metformin, which decreases hepatic glucose production and improves insulin sensitivity. This combination is effective in managing type 2 diabetes.

Indications:

• Treatment of type 2 diabetes in adults when diet, exercise, and monotherapy are insufficient.

• Can be used alone or with other antidiabetic agents.

Dosage:

• Typically one tablet twice daily with meals.

• Dose adjusted according to blood glucose levels and patient tolerance.

Contraindications:

• Type 1 diabetes

• Diabetic ketoacidosis

• Severe renal or hepatic impairment

• Hypersensitivity to sitagliptin, metformin, or excipients

Warnings:

• Monitor kidney function regularly

• Risk of lactic acidosis (rare but serious)

• Caution in liver or heart disease

• Not recommended during pregnancy or breastfeeding

Side Effects:

• Gastrointestinal discomfort

• Hypoglycemia (especially with insulin or sulfonylureas)

• Headache

Storage:
Store below 30°C in a dry place, away from sunlight.